Copyright Reports & Markets. All rights reserved.

Global Immunoinformatics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Immunoinformatics
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Immunoinformatics by Type
    • 1.3.1 Overview: Global Immunoinformatics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Immunoinformatics Consumption Value Market Share by Type in 2023
    • 1.3.3 Cancer Diagnosis & Therapy
    • 1.3.4 Reverse Vaccinology
    • 1.3.5 Immune System Modeling
  • 1.4 Global Immunoinformatics Market by Application
    • 1.4.1 Overview: Global Immunoinformatics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Allergy Prediction Databases
    • 1.4.3 Analysis Resource Database
    • 1.4.4 International Immunogenetics System
    • 1.4.5 The Ontology of Immune Epitopes
    • 1.4.6 Immune Epitope Database
  • 1.5 Global Immunoinformatics Market Size & Forecast
  • 1.6 Global Immunoinformatics Market Size and Forecast by Region
    • 1.6.1 Global Immunoinformatics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Immunoinformatics Market Size by Region, (2019-2030)
    • 1.6.3 North America Immunoinformatics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Immunoinformatics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Immunoinformatics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Immunoinformatics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa Immunoinformatics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 EpiVax
    • 2.1.1 EpiVax Details
    • 2.1.2 EpiVax Major Business
    • 2.1.3 EpiVax Immunoinformatics Product and Solutions
    • 2.1.4 EpiVax Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 EpiVax Recent Developments and Future Plans
  • 2.2 Novozymes Biopharma
    • 2.2.1 Novozymes Biopharma Details
    • 2.2.2 Novozymes Biopharma Major Business
    • 2.2.3 Novozymes Biopharma Immunoinformatics Product and Solutions
    • 2.2.4 Novozymes Biopharma Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Novozymes Biopharma Recent Developments and Future Plans
  • 2.3 ioGenetics
    • 2.3.1 ioGenetics Details
    • 2.3.2 ioGenetics Major Business
    • 2.3.3 ioGenetics Immunoinformatics Product and Solutions
    • 2.3.4 ioGenetics Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 ioGenetics Recent Developments and Future Plans
  • 2.4 International Society of Vaccines
    • 2.4.1 International Society of Vaccines Details
    • 2.4.2 International Society of Vaccines Major Business
    • 2.4.3 International Society of Vaccines Immunoinformatics Product and Solutions
    • 2.4.4 International Society of Vaccines Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 International Society of Vaccines Recent Developments and Future Plans
  • 2.5 IMGT
    • 2.5.1 IMGT Details
    • 2.5.2 IMGT Major Business
    • 2.5.3 IMGT Immunoinformatics Product and Solutions
    • 2.5.4 IMGT Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 IMGT Recent Developments and Future Plans
  • 2.6 Dassault Systemes
    • 2.6.1 Dassault Systemes Details
    • 2.6.2 Dassault Systemes Major Business
    • 2.6.3 Dassault Systemes Immunoinformatics Product and Solutions
    • 2.6.4 Dassault Systemes Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Dassault Systemes Recent Developments and Future Plans
  • 2.7 Certara
    • 2.7.1 Certara Details
    • 2.7.2 Certara Major Business
    • 2.7.3 Certara Immunoinformatics Product and Solutions
    • 2.7.4 Certara Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Certara Recent Developments and Future Plans
  • 2.8 Chemical Computing Group
    • 2.8.1 Chemical Computing Group Details
    • 2.8.2 Chemical Computing Group Major Business
    • 2.8.3 Chemical Computing Group Immunoinformatics Product and Solutions
    • 2.8.4 Chemical Computing Group Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Chemical Computing Group Recent Developments and Future Plans
  • 2.9 Compugen
    • 2.9.1 Compugen Details
    • 2.9.2 Compugen Major Business
    • 2.9.3 Compugen Immunoinformatics Product and Solutions
    • 2.9.4 Compugen Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Compugen Recent Developments and Future Plans
  • 2.10 Genedata AG
    • 2.10.1 Genedata AG Details
    • 2.10.2 Genedata AG Major Business
    • 2.10.3 Genedata AG Immunoinformatics Product and Solutions
    • 2.10.4 Genedata AG Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Genedata AG Recent Developments and Future Plans
  • 2.11 Insilico Biotechnology AG
    • 2.11.1 Insilico Biotechnology AG Details
    • 2.11.2 Insilico Biotechnology AG Major Business
    • 2.11.3 Insilico Biotechnology AG Immunoinformatics Product and Solutions
    • 2.11.4 Insilico Biotechnology AG Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Insilico Biotechnology AG Recent Developments and Future Plans
  • 2.12 Leadscope Inc
    • 2.12.1 Leadscope Inc Details
    • 2.12.2 Leadscope Inc Major Business
    • 2.12.3 Leadscope Inc Immunoinformatics Product and Solutions
    • 2.12.4 Leadscope Inc Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Leadscope Inc Recent Developments and Future Plans
  • 2.13 Nimbus Discovery
    • 2.13.1 Nimbus Discovery Details
    • 2.13.2 Nimbus Discovery Major Business
    • 2.13.3 Nimbus Discovery Immunoinformatics Product and Solutions
    • 2.13.4 Nimbus Discovery Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Nimbus Discovery Recent Developments and Future Plans
  • 2.14 Strand Life Sciences
    • 2.14.1 Strand Life Sciences Details
    • 2.14.2 Strand Life Sciences Major Business
    • 2.14.3 Strand Life Sciences Immunoinformatics Product and Solutions
    • 2.14.4 Strand Life Sciences Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Strand Life Sciences Recent Developments and Future Plans
  • 2.15 Schrodinger
    • 2.15.1 Schrodinger Details
    • 2.15.2 Schrodinger Major Business
    • 2.15.3 Schrodinger Immunoinformatics Product and Solutions
    • 2.15.4 Schrodinger Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Schrodinger Recent Developments and Future Plans
  • 2.16 Simulation Plus
    • 2.16.1 Simulation Plus Details
    • 2.16.2 Simulation Plus Major Business
    • 2.16.3 Simulation Plus Immunoinformatics Product and Solutions
    • 2.16.4 Simulation Plus Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Simulation Plus Recent Developments and Future Plans
  • 2.17 Rosa & Co
    • 2.17.1 Rosa & Co Details
    • 2.17.2 Rosa & Co Major Business
    • 2.17.3 Rosa & Co Immunoinformatics Product and Solutions
    • 2.17.4 Rosa & Co Immunoinformatics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 Rosa & Co Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Immunoinformatics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Immunoinformatics by Company Revenue
    • 3.2.2 Top 3 Immunoinformatics Players Market Share in 2023
    • 3.2.3 Top 6 Immunoinformatics Players Market Share in 2023
  • 3.3 Immunoinformatics Market: Overall Company Footprint Analysis
    • 3.3.1 Immunoinformatics Market: Region Footprint
    • 3.3.2 Immunoinformatics Market: Company Product Type Footprint
    • 3.3.3 Immunoinformatics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Immunoinformatics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Immunoinformatics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Immunoinformatics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Immunoinformatics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Immunoinformatics Consumption Value by Type (2019-2030)
  • 6.2 North America Immunoinformatics Consumption Value by Application (2019-2030)
  • 6.3 North America Immunoinformatics Market Size by Country
    • 6.3.1 North America Immunoinformatics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Immunoinformatics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Immunoinformatics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Immunoinformatics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Immunoinformatics Consumption Value by Type (2019-2030)
  • 7.2 Europe Immunoinformatics Consumption Value by Application (2019-2030)
  • 7.3 Europe Immunoinformatics Market Size by Country
    • 7.3.1 Europe Immunoinformatics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Immunoinformatics Market Size and Forecast (2019-2030)
    • 7.3.3 France Immunoinformatics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Immunoinformatics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Immunoinformatics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Immunoinformatics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Immunoinformatics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Immunoinformatics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Immunoinformatics Market Size by Region
    • 8.3.1 Asia-Pacific Immunoinformatics Consumption Value by Region (2019-2030)
    • 8.3.2 China Immunoinformatics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Immunoinformatics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Immunoinformatics Market Size and Forecast (2019-2030)
    • 8.3.5 India Immunoinformatics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Immunoinformatics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Immunoinformatics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Immunoinformatics Consumption Value by Type (2019-2030)
  • 9.2 South America Immunoinformatics Consumption Value by Application (2019-2030)
  • 9.3 South America Immunoinformatics Market Size by Country
    • 9.3.1 South America Immunoinformatics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Immunoinformatics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Immunoinformatics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Immunoinformatics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Immunoinformatics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Immunoinformatics Market Size by Country
    • 10.3.1 Middle East & Africa Immunoinformatics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Immunoinformatics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Immunoinformatics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Immunoinformatics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Immunoinformatics Market Drivers
  • 11.2 Immunoinformatics Market Restraints
  • 11.3 Immunoinformatics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Immunoinformatics Industry Chain
  • 12.2 Immunoinformatics Upstream Analysis
  • 12.3 Immunoinformatics Midstream Analysis
  • 12.4 Immunoinformatics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Immunoinformatics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
    Immunoinformatics is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.
    The Global Info Research report includes an overview of the development of the Immunoinformatics industry chain, the market status of Allergy Prediction Databases (Cancer Diagnosis & Therapy, Reverse Vaccinology), Analysis Resource Database (Cancer Diagnosis & Therapy, Reverse Vaccinology), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Immunoinformatics.
    Regionally, the report analyzes the Immunoinformatics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Immunoinformatics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Immunoinformatics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Immunoinformatics industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cancer Diagnosis & Therapy, Reverse Vaccinology).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Immunoinformatics market.
    Regional Analysis: The report involves examining the Immunoinformatics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Immunoinformatics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Immunoinformatics:
    Company Analysis: Report covers individual Immunoinformatics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Immunoinformatics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Allergy Prediction Databases, Analysis Resource Database).
    Technology Analysis: Report covers specific technologies relevant to Immunoinformatics. It assesses the current state, advancements, and potential future developments in Immunoinformatics areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Immunoinformatics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Immunoinformatics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
    Market segment by Type
    Cancer Diagnosis & Therapy
    Reverse Vaccinology
    Immune System Modeling
    Market segment by Application
    Allergy Prediction Databases
    Analysis Resource Database
    International Immunogenetics System
    The Ontology of Immune Epitopes
    Immune Epitope Database
    Market segment by players, this report covers
    EpiVax
    Novozymes Biopharma
    ioGenetics
    International Society of Vaccines
    IMGT
    Dassault Systemes
    Certara
    Chemical Computing Group
    Compugen
    Genedata AG
    Insilico Biotechnology AG
    Leadscope Inc
    Nimbus Discovery
    Strand Life Sciences
    Schrodinger
    Simulation Plus
    Rosa & Co
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Immunoinformatics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Immunoinformatics, with revenue, gross margin and global market share of Immunoinformatics from 2019 to 2024.
    Chapter 3, the Immunoinformatics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Immunoinformatics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
    Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Immunoinformatics.
    Chapter 13, to describe Immunoinformatics research findings and conclusion.

    Buy now